Clinical Trials Logo

Malignant Solid Tumors clinical trials

View clinical trials related to Malignant Solid Tumors.

Filter by:
  • Not yet recruiting  
  • Page 1

NCT ID: NCT06082557 Not yet recruiting - Clinical trials for Malignant Solid Tumors

A Study to Observe and Evaluate the Safety and Efficacy of T60c Injection for Treatment of Advanced Solid Tumor Patients

Start date: October 2023
Phase: Phase 1/Phase 2
Study type: Interventional

This is an open-labeled, single-arm, multiple-dose escalation and single-dose expansion clinical study of cell therapy to observe and evaluate the safety and efficacy of T60c injection in the treatment of patients with advanced solid tumors

NCT ID: NCT05508620 Not yet recruiting - Clinical trials for Malignant Solid Tumors

A Study of Sirolimus for Injection (Albumin-bound) in Patients With Advanced Solid Tumors

Start date: October 2022
Phase: Phase 1
Study type: Interventional

This is an open-label, multi-center phase 1b study to evaluate the safety and efficacy of Sirolimus for injection (albumin-bound) in patients with malignant solid tumors with TSC1 or TSC2 genetic alterations.